AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Transform your budget into a powerful savings tool with these optimization techniques. Improve your financial situation now!
18,515 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Investors are weighing two value plays: VLUE leans on the value factor itself, while VTV sticks with mega-cap, discou...
June’s producer price index fell 0.3% from May as energy prices slid, signaling cooling inflation. Yet geopolitical t...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
Verizon raises its dividend with a high yield, while Johnson & Johnson offers steadier growth and a long payout histo...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Snow-season demand shapes profitability for snow equipment makers. This article breaks down douglas dynamics (plow) e...
As markets wobble in early 2026, preferred shares matter for investors seeking steady income and lower drama than gro...
This fresh analysis explores intuit (intu) 2026 earnings, highlighting key growth drivers, profitability advances, an...
Crypto markets stay volatile and 24/7 in 2026, pushing funded trading models to the fore. This report profiles the to...
Geopolitical tensions in the Middle East drive a sharp jump in U.S. gasoline prices, rattling consumer budgets and br...